2-bromo-4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazole;N-[4-[4-(2,4-dichlorophenyl)-5-(1H-imidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-[4-[4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-(4-trimethylstannyl-2-pyridinyl)acetamide
C66H56BrCl6N15O3S3Sn — CID 161202392
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-bromo-4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazole;N-[4-[4-(2,4-dichlorophenyl)-5-(1H-imidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-[4-[4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-(4-trimethylstannyl-2-pyridinyl)acetamide
2-bromo-4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazole;N-[4-[4-(2,4-dichlorophenyl)-5-(1H-imidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-[4-[4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-(4-trimethylstannyl-2-pyridinyl)acetamide (PubChem CID 161202392) has the molecular formula C66H56BrCl6N15O3S3Sn and a molecular weight of 1614.81 g/mol. Its IUPAC name is 2-bromo-4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazole;N-[4-[4-(2,4-dichlorophenyl)-5-(1H-imidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-[4-[4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-(4-trimethylstannyl-2-pyridinyl)acetamide.
Molecular Properties
| Compound Name | 2-bromo-4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazole;N-[4-[4-(2,4-dichlorophenyl)-5-(1H-imidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-[4-[4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-(4-trimethylstannyl-2-pyridinyl)acetamide |
|---|---|
| PubChem CID | 161202392 |
| Molecular Formula | C66H56BrCl6N15O3S3Sn |
| Molecular Weight | 1614.81 g/mol |
| Exact Mass | 1611.02 |
| IUPAC Name | 2-bromo-4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazole;N-[4-[4-(2,4-dichlorophenyl)-5-(1H-imidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-[4-[4-(2,4-dichlorophenyl)-5-(1-prop-2-enylimidazol-2-yl)-1,3-thiazol-2-yl]-2-pyridinyl]acetamide;N-(4-trimethylstannyl-2-pyridinyl)acetamide |
| SMILES | C=CCn1ccnc1-c1sc(-c2ccnc(NC(C)=O)c2)nc1-c1ccc(Cl)cc1Cl.C=CCn1ccnc1-c1sc(Br)nc1-c1ccc(Cl)cc1Cl.CC(=O)Nc1cc(-c2nc(-c3ccc(Cl)cc3Cl)c(-c3ncc[nH]3)s2)ccn1.CC(=O)Nc1cc([Sn](C)(C)C)ccn1 |
| InChI | InChI=1S/C22H17Cl2N5OS.C19H13Cl2N5OS.C15H10BrCl2N3S.C7H7N2O.3CH3.Sn/c1-3-9-29-10-8-26-21(29)20-19(16-5-4-15(23)12-17(16)24)28-22(31-20)14-6-7-25-18(11-14)27-13(2)30;1-10(27)25-15-8-11(4-5-22-15)19-26-16(13-3-2-12(20)9-14(13)21)17(28-19)18-23-6-7-24-18;1-2-6-21-7-5-19-14(21)13-12(20-15(16)22-13)10-4-3-9(17)8-11(10)18;1-6(10)9-7-4-2-3-5-8-7;;;;/h3-8,10-12H,1,9H2,2H3,(H,25,27,30);2-9H,1H3,(H,23,24)(H,22,25,27);2-5,7-8H,1,6H2;3-5H,1H3,(H,8,9,10);3*1H3; |
| InChIKey | UVDQSKCKWGVPEY-UHFFFAOYSA-N |
| XLogP | 19.23 |
| TPSA | 228.96 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 95 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1614.81 |
| LogP ≤ 5 | 19.23 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 17 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161202392 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.